SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCaledonia Regulatory News (CLDN)

Share Price Information for Caledonia (CLDN)

Share Price is delayed by 15 minutes
Get Live Data
355.50    5.50 (1.57%)
Bid:
354.00
Ask:
358.00
Spread: 4.00 (1.13%)
Market Cap: £1.82b
CLDN Live PriceLast checked at - London Stock Exchange

Intraday Caledonia Share Chart

Director/PDMR Shareholding

10 Dec 2013 11:23

RNS Number : 1596V
Caledonia Investments PLC
10 December 2013
Β 

ο»Ώ

NOTIFICATION OF TRANSACTION OF DIRECTORS/PERSONS DISCHARGING MANAGERIAL RESPONSIBIILTY AND CONNECTED PERSONS

Β 

This form is intended for use by an issuer to make a RIS notification required by DR 3.1.4R(1).

Β 

(i) An issuer making a notification in respect of a transaction relating to the shares or debentures of the issuer should complete boxes 1 to 16, 23 and 24.

Β 

(ii) An issuer making a notification in respect of a derivative relating to the shares of the issuer should complete boxes 1 to 4, 6, 8, 13, 14, 16, 23 and 24.

Β 

(iii) An issuer making a notification in respect of options granted to a director / person discharging managerial responsibilities should complete boxes 1 to 3 and 17 to 24.

Β 

(iv) An issuer making a notification in respect of a financial instrument relating to the shares of the issuer (other than a debenture) should complete boxes 1 to 4, 6, 8, 9, 11, 13, 14, 16, 23 and 24.

Β 

Β 

1

Name of the issuer:

Β 

Β 

CALEDONIA INVESTMENTS PLC

2

The notification relates to a transaction notified in accordance with:

Β 

DR 3.1.4R(1)(a).

Β 

3

Name of person discharging managerial responsibilities / director:

Β 

Β 

Β 

R D KENT

4

State whether the notification relates to a person connected with a person discharging managerial responsibilities /director named in 3 and identify the connected person:

Β 

N/A

Β 

5

Indicate whether the notification is in respect of a holding of the person referred to in 3 or 4 above or in respect of a non-beneficial interest:

Β 

BENEFICIAL HOLDING OF PERSON NAMED IN 3

Β 

6

Description of shares, debentures, derivatives or financial instruments relating to shares:

Β 

Β 

Β 

ORDINARY 5P SHARES

7

Name of registered shareholder and, if more than one, the number of shares held by each of them:

Β 

REYKER NOMINEES LIMITED A/C TFI

8

State the nature of the transaction:

Β 

Β 

Β 

PURCHASE OF SHARES

Β 

9

Number of shares acquired.

Β 

Β 

10,000

Β 

10

Percentage of issued class acquired (excluding treasury shares)

Β 

0.02%

Β 

11

Number of shares disposed:

Β 

NONE

12

Percentage of issued class disposed

Β 

NONE

Β 

Β 

13

Price per share or value of transaction

Β 

Β£19.13998 PER SHARE

Β 

Β 

Β 

Β 

Β 

14

Date and place of transaction

Β 

10 DECEMBER 2013, LONDON

15

Total holding and total percentage holding (excluding treasury shares)

Β 

Beneficial - 10,000 shares (0.02%)

Β 

16

Date issuer informed of transaction

Β 

Β 

Β 

17

Date of grant

Β 

Β 

N/A

18

Period during which or date on which it can be exercised

Β 

N/A

Β 

19

Total amount paid (if any) for grant of the option

Β 

N/A

Β 

20

Description of shares or debentures involved

Β 

N/A

21

Exercise price (if fixed at time of grant) or indication that price is to be fixed at the time of exercise

Β 

N/A

22

Total number of shares or debentures over which options held following notification

Β 

N/A

Β 

Β 

23

Any additional information

Β 

NONE

24

Name of contact and telephone number for queries

Β 

K M BURWOOD

+44 20 7802 8080

Β 

Name and signature of duly authorised officer of issuer responsible for making notification

Β 

K M BURWOOD

DEPUTY COMPANY SECRETARY

Β 

Date of notification

10 DECEMBER 2013

Β 

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
RDSFFEFFSFDSEEE
Date   Source Headline
20th Apr 20267:00 amRNSTransaction in Own Shares
17th Apr 20267:00 amRNSTransaction in Own Shares
16th Apr 20267:00 amRNSTransaction in Own Shares
15th Apr 20267:00 amRNSTransaction in Own Shares
14th Apr 20267:00 amRNSTransaction in Own Shares
13th Apr 20267:00 amRNSTransaction in Own Shares
10th Apr 20267:00 amRNSTransaction in Own Shares
9th Apr 20267:00 amRNSNet Asset Value(s)
9th Apr 20267:00 amRNSTransaction in Own Shares
8th Apr 20267:00 amRNSTransaction in Own Shares
7th Apr 20267:00 amRNSTransaction in Own Shares
2nd Apr 20267:00 amRNSTransaction in Own Shares
1st Apr 20267:00 amRNSTotal Voting Rights
1st Apr 20267:00 amRNSTransaction in Own Shares
31st Mar 202611:00 amRNSIrrevocable Share Repurchase Instruction
30th Mar 20264:24 pmRNSDirector/PDMR Shareholding
26th Mar 20267:00 amRNSTransaction in Own Shares
25th Mar 20267:00 amRNSTransaction in Own Shares
24th Mar 20267:00 amRNSTransaction in Own Shares
23rd Mar 20267:00 amRNSTransaction in Own Shares
20th Mar 20267:00 amRNSTransaction in Own Shares
19th Mar 20269:05 amRNS-RUpdate from QuotedData
19th Mar 20267:00 amRNSTransaction in Own Shares
18th Mar 20267:00 amRNSTransaction in Own Shares
17th Mar 20267:00 amRNSTransaction in Own Shares
16th Mar 20267:00 amRNSTransaction in Own Shares
13th Mar 20267:00 amRNSTransaction in Own Shares
11th Mar 20261:48 pmRNSDirector/PDMR Shareholding
11th Mar 20267:00 amRNSTransaction in Own Shares
10th Mar 20267:00 amRNSTransaction in Own Shares
9th Mar 20267:00 amRNSTransaction in Own Shares
6th Mar 20267:00 amRNSTransaction in Own Shares
5th Mar 202610:30 amRNSNet Asset Value(s)
5th Mar 20267:00 amRNSTransaction in Own Shares
2nd Mar 20264:37 pmRNSDirector/PDMR Shareholding
2nd Mar 20267:00 amRNSTotal Voting Rights
2nd Mar 20267:00 amRNSTransaction in Own Shares
23rd Feb 20267:00 amRNSTransaction in Own Shares
20th Feb 20267:00 amRNSTransaction in Own Shares
19th Feb 20267:00 amRNSTransaction in Own Shares
18th Feb 20267:00 amRNSTransaction in Own Shares
17th Feb 20267:00 amRNSTransaction in Own Shares
16th Feb 20267:00 amRNSTransaction in Own Shares
13th Feb 20267:00 amRNSTransaction in Own Shares
11th Feb 20269:57 amRNSDirector/PDMR Shareholding
11th Feb 20267:00 amRNSTransaction in Own Shares
10th Feb 20267:00 amRNSTransaction in Own Shares
9th Feb 20267:00 amRNSTransaction in Own Shares
6th Feb 20267:00 amRNSTransaction in Own Shares
5th Feb 202611:00 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.